The goal of the recent study was to investigate the effect of basal insulin treatment, by adding insulin GLA or NPH insulin to metformin, on postprandial β-cell function in patients with type 2 diabetes using a combination of metformin and sulfonylurea. Here, INS is linked to type 2 diabetes mellitus.